FDA warning letters target marketers of unapproved weight loss drugs RAPS The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News